Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Platelet activation at different time intervals after aspirin intake
NL-OMON39536Active, not recruiting
- Sponsor
- Vrije University Medical Center
- Start
- Jul 2013
- Modality
- Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Open-label, single-arm trial of aspirin in thromboembolism, myocardial infarction (MI) and ischemic stroke, sponsored by Vrije University Medical Center. Primary endpoint: Platelet activability by PFA-200. Started Jul 2013; status: active, not recruiting.
02
Drugs
aspirin
03
Conditions
thromboembolismmyocardial infarction (MI)ischemic stroke
Beyond the preview
Go deeper on NL-OMON39536.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NL-OMON39536.